News Article | April 17, 2017
On Tuesday, April 4, SAE International honored members of the General Motors Research Laboratories Fuels and Lubricants Department with the 2016 SAE Arnold W. Siegel Humanitarian Award. The team was recognized for its many significant contributions to automotive technology through their pioneering research to improve engine combustion efficiency, understand engine knock, define and reduce vehicle emissions, and improve fuel and lubricant quality on a worldwide basis. Established in 2014, the Arnold W. Siegel Humanitarian Award is made possible by a generous gift from Arnold and Stephanie Siegel. The award proudly represents members and non-members of SAE International whose mobility industry contributions have made a lasting social benefit on humanity. The award honors individuals, teams, organizations or entities, both domestic and internationally, whose mobility industry contributions - research or practical application - have made a significant, positive, multi-generational impact on the world such as, but not limited to: mobility safety or the environment, creating a safer, healthier world. The Fuels and Lubricants team was instrumental in the development of the exhaust catalytic converter; they supplied the data to substantiate the need for unleaded gasoline, defined the properties of clean (“reformulated”) gasoline and promoted its use. They solved the major engine port fuel injector problem which was prevalent in the auto industry in the mid-1980s and developed the Engine Oil Change Indicator, now extensively used on all of GM’s vehicles. The positive impact made by this team to improve fuel and lubricant quality in the United States and around the globe, was based on rigorous engine, automatic transmission, and axle testing which has become the standard for many performance-based specifications for automotive fuels and lubricants. This has resulted in reduced maintenance costs and increased life for engines and drivetrains. The team members listed below led the efforts of the hundreds of people who did the work acknowledged in the award. SAE International is a global association committed to being the ultimate knowledge source for the mobility engineering profession. By uniting more than 127,000 engineers and technical experts worldwide, we drive knowledge and expertise across a broad spectrum of industries. We act on two priorities: encouraging a lifetime of learning for mobility engineering professionals and setting the standards for industry engineering. We strive for a better world through the work of our philanthropic SAE Foundation, including programs like A World in Motion® and the Collegiate Design Series™.
News Article | April 25, 2017
Advance Anesthesia Monitoring Devices Market Information by Type (gas monitors, standalone capnography monitors, depth of anesthesia, and MRI compatible anesthesia monitors), by End User (Hospitals, Clinics, ambulatory services) - Forecast to 2027Pune, India - April 25, 2017 /MarketersMedia/ — The various major growth of the market is due to immense growth of the application such as include target products & services, Develop new product, target patients, digital marketing and others. Hottest trend in the market All systems that include anesthesia require solid anesthesia monitors to keep up patient security. There are a few types of anesthesia monitors and related medicinal equipment being used. The decision of proper monitoring equipment relies on upon the kind of cases to be performed in a specific setting. The American Society of Anesthesiologists suggests that a patient experiencing anesthesia be checked for heart rate, pulse, oxygen immersion, carbon dioxide, oxygen levels, and different vitals. Key Players • Nihon Kohden Corporation (China) • GE Healthcare (U.K.) • Philips Healthcare (The Netherlands) • Draegerwerk AG & Co. KGaA (Germany) • Masimo (U.S.) • Infinium Medical (U.S.) • Medtronic (U.S.) • Mindray Medical International Limited (China) Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1071 Market Scenario Globally the market for Advance Anesthesia Monitoring Devices is increasing rapidly the main reason for this is the growth in safety of patients. The factors that influence the growth of Advance Anesthesia Monitoring Devices Market are the increasing technology development in healthcare devices, Healthcare organizations encouraging patients to go undergo anesthesia monitoring. The market is also growing due to usage of Advance Anesthesia Monitoring Devices in wide range of treatment. Segments By Type o Gas Monitors o Standalone Capnography Monitors o Depth Of Anesthesia o Mri Compatible Anesthesia Monitors By End-Users o Hospitals o Research Laboratories o Clinics o Ambulatory Services Table of Content 1. Report prologue 2. Introduction 2.1 Definition 2.2 Scope of the study 2.2.1 Research objective 2.2.2 Assumptions 2.2.3 Limitations 2.3 Market structure 3. Research Methodology 3.1 Research process 3.2 Primary research 3.3 Secondary research 3.4 Market size estimation 3.5 Forecast model 4. Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 5. Market factor analysis 5.1 Value chain analysis/Supply chain analysis 5.2 Porters five forces 5.2.1. Bargaining Power of suppliers 5.2.2. Bargaining Power of Customer 5.2.3. Intensity of Competitor’s 5.2.4. Threat of New Entrants 5.2.5 Threat of Substitutes Continue……. Browse Report @ https://www.marketresearchfuture.com/reports/advance-anesthesia-monitoring-devices-market The report for Advance Anesthesia Monitoring Devices of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. Related Report Global Astigmatism Market Information, by type (Myopic Astigmatism, Hyperopic Astigmatism and others), by treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries and others), by end user (Hospital, Clinics and others) - Forecast to 2022 https://www.marketresearchfuture.com/reports/astigmatism-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Info:Name: Akash AnandEmail: email@example.comOrganization: Market Research FutureAddress: Office No. 528, Amanora Chambers Magarpatta Road, HadapsarPhone: +1 646 845 9312Source URL: http://marketersmedia.com/advance-anesthesia-monitoring-devices-market-2017-to-2027-global-key-vendors-analysis-revenue-trends-and-forecast/189937For more information, please visit https://www.marketresearchfuture.com/reports/advance-anesthesia-monitoring-devices-marketSource: MarketersMediaRelease ID: 189937
News Article | April 25, 2017
Orphan Diseases Market is expected to grow at the average CAGR of 24.9% constantly throughout this period 2015-2022 and It is also expected that this market which was US$ 121.6 billion | Orphan Diseases Marketpune, India - April 25, 2017 /MarketersMedia/ — Global orphan diseases market was estimated to be around US$ 121.6 billion in 2015 and is expected to reach US$ 576.9 billion by 2022 by growing at a CAGR of 24.9%. Market Highlight The global orphan diseases market has been evaluated to be rapidly growing market and it is expected that it will grow at tremendous rate in the future. Orphan diseases are mostly genetic and exists lifelong with the patient; they are also known as rare diseases and affects small number of patient population. About 80% of orphan disease disorders are genetic. Rising consumer awareness and continuous development of treatment for orphan diseases are driving the growth of this market. Major drugs manufacturers are looking positively towards the orphan disease drug segment and investing huge amount in R&D of the same. Many countries are forming norms and acts for the treatment and cure of orphan diseases. There are several factors which are prohibiting the growth of this market which includes extremely high cost of orphan disease treatment and drugs and absence of correct diagnosis, appropriate treatment, healthcare facilities, and information about the orphan disease disorders etc. Request for Sample Report@ https://www.marketresearchfuture.com/sample_request/2547 Regional Analysis: Depending on the geographic region, orphan diseases market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, North America comprise the largest market share of the global orphan diseases market. Moreover the European market is also growing continuously and slowly catching up with the growth and volume of the American market and is expected to maintain this in the future as well. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the future. Rest of the World is likely to have a limited but steady growth with respect to this market. Key Player • Bristol-Myers Squibb Company (US) • Novartis AG (Switzerland) • CELGENE CORPORATION (US) • F. Hoffmann-La Roche Ltd (Switzerland) • Pfizer Inc. (US) • Alexion (US) • Sanofi (France) • Vertex Pharmaceuticals Incorporated (US) • GlaxoSmithKline plc. (UK) • Merck & Co., Inc (US) • AbbVie Inc. (US) Segmentation By Type - Genetic Disorders, Blood Disorders, Cancer, Growth Disorder, Cardiovascular Diseases, Neurological Disorders, Eye Disorders and Others By Type - Treatment Gene Therapy, Cell Therapy, Drug Therapy and Others By End User - Hospital and Clinics, Research Laboratory and Others By Region: North America, Asia-Pacific, Europe and Row Browse Full OD Market @ https://www.marketresearchfuture.com/reports/orphan-diseases-market-2547 Taste the market data and market information presented in more than 78 market data tables and figures spread in 85 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Orphan Diseases Market Research Report –Global Forecast to 2022.” Intended Audience • Hospitals and clinics • Orphan diseases drug manufacturers and suppliers • Government and independent regulatory authorities • Research and development (R&D) companies • Market research and consulting service providers • Medical research laboratories • Potential investors • Table of Content 1 Report Prologue 2 Market Introduction 3 Research Methodology 3.1 Research Process 3.2 Primary Research 4 Market Dynamics 4.1 Drivers 4.2 Restraints 5 Market Factor Analysis 5.1 Value/Supply Chain Analysis 5.2 Porter's 5 Forces Analysis 5.3 Pricing Analysis 6 Global Orphan diseases Market Market, By Disease Type (USD Million) 6.1 Autoimmune Disorders 6.2 Genetic Disorders 6.3 Blood Disorders 6.4 Cancer 7 Chronic Disease Management Market, By Treatment Type (USD Million) 7.1 Gene Therapy 7.2 Drug Therapy 7.3 Drug Therapy 8 Global Chronic Disease Management Market, By End User (USD Million) 8.1 Hospitals and Clinics 8.2 Research Laboratories 9 Global Orphan Disease Market, By Region (USD Million) Continued…… About Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Info:Name: Akash AnandOrganization: Market Research futureAddress: Market Research Future Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312Phone: 6468459312Source URL: http://marketersmedia.com/global-orphan-diseases-market-was-estimated-to-be-around-usd-121-6-billion/189928For more information, please visit https://www.marketresearchfuture.com/reports/orphan-diseases-market-2547Source: MarketersMediaRelease ID: 189928
News Article | April 23, 2017
Receive press releases from iHealthcareAnalyst, Inc.: By Email Tissue Diagnostics Market by Products, Technologies, End Users, Growth Trends and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Maryland Heights, MO, April 23, 2017 --( Browse Tissue Diagnostics Market by Product Type (Instruments, Kits), Technology (Digital Pathology, Immunohistochemistry, Is-Situ Hybridization, Special Staining), End Users (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/tissue-diagnostics-market/. The global tissue diagnostics market segmentation is based on product type (instruments, kits), technology (digital pathology, immunohistochemistry, in-situ hybridization, special staining), end users (ambulatory surgical centers, diagnostic centers, hospitals). The global tissue diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global tissue diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global tissue diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global tissue diagnostics market and profiled in this report include 3DHISTECH Ltd., Abbott Laboratories, Agilent Technologies, Becton Dickinson & Company, Cell Signaling Technologies, Danaher Corporation, GE Healthcare, Genomic Health, Inc., Roche Diagnostics (Ventana Medical Systems), and Thermo Fisher Scientific, Inc. 1. Product Type 1.1. Instruments 1.2. Kits 2. Technology 2.1. Digital Pathology 2.2. Immunohistochemistry 2.3. In-Situ Hybridization 2.4. Special Staining 3. End Users 3.1. Ambulatory Surgical Centers 3.2. Diagnostic Centers 3.3. Hospitals 3.4. Research Laboratories 4. Geography (Region, Country) 4.1. North America (U.S., Canada) 4.2. Latin America (Brazil, Mexico, Rest of LA) 4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 4.4. Asia Pacific (Japan, China, India, Rest of APAC) 4.5. Rest of the World 5. Company profiles 5.1. 3DHISTECH Ltd. 5.2. Abbott Laboratories 5.3. Agilent Technologies 5.4. Becton Dickinson & Company 5.5. Cell Signaling Technologies 5.6. Danaher Corporation 5.7. GE Healthcare 5.8. Genomic Health, Inc. 5.9. Roche Diagnostics (Ventana Medical Systems) 5.10. Thermo Fisher Scientific, Inc. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/tissue-diagnostics-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive Maryland Heights, MO 63043 United States Email: firstname.lastname@example.org Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, April 23, 2017 --( PR.com )-- Soft-tissue sarcomas are rare, comprising 100 benign and malignant soft-tissue tumor entities defined. Tissue diagnostics helps pathologists recommend treatment solutions that deliver superior patient care. Diagnosis based on examination of tissue can provide information on exact tumor type and degree of malignancy and helps to identify potential causes and consequences. The tissue diagnostics instrument, reagents and digital pathology systems are used in clinical histology, cytology, and drug discovery laboratories around the globe. Demand for excised human tissue is increasing because of the realization of personalized medicine, which relies on excised human tissue to develop innovative tests for application in patient care.Browse Tissue Diagnostics Market by Product Type (Instruments, Kits), Technology (Digital Pathology, Immunohistochemistry, Is-Situ Hybridization, Special Staining), End Users (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/tissue-diagnostics-market/.The global tissue diagnostics market segmentation is based on product type (instruments, kits), technology (digital pathology, immunohistochemistry, in-situ hybridization, special staining), end users (ambulatory surgical centers, diagnostic centers, hospitals).The global tissue diagnostics market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global tissue diagnostics market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global tissue diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global tissue diagnostics market and profiled in this report include 3DHISTECH Ltd., Abbott Laboratories, Agilent Technologies, Becton Dickinson & Company, Cell Signaling Technologies, Danaher Corporation, GE Healthcare, Genomic Health, Inc., Roche Diagnostics (Ventana Medical Systems), and Thermo Fisher Scientific, Inc.1. Product Type1.1. Instruments1.2. Kits2. Technology2.1. Digital Pathology2.2. Immunohistochemistry2.3. In-Situ Hybridization2.4. Special Staining3. End Users3.1. Ambulatory Surgical Centers3.2. Diagnostic Centers3.3. Hospitals3.4. Research Laboratories4. Geography (Region, Country)4.1. North America (U.S., Canada)4.2. Latin America (Brazil, Mexico, Rest of LA)4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)4.4. Asia Pacific (Japan, China, India, Rest of APAC)4.5. Rest of the World5. Company profiles5.1. 3DHISTECH Ltd.5.2. Abbott Laboratories5.3. Agilent Technologies5.4. Becton Dickinson & Company5.5. Cell Signaling Technologies5.6. Danaher Corporation5.7. GE Healthcare5.8. Genomic Health, Inc.5.9. Roche Diagnostics (Ventana Medical Systems)5.10. Thermo Fisher Scientific, Inc.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/tissue-diagnostics-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: email@example.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.
News Article | February 18, 2017
The Red Carpet Luxury Lounge benefiting NKLA - a Best Friends Animal Society initiative - will be buzzing this year as it opens its doors to Hollywood's hottest talent surrounding the award show festivities. Nominees and other celebrity talent as well as producers, directors, stylists, press and media will gain access to new and exciting products and services offered by Secret Room Events amazing array of sponsors. Guests will be able to nibble on food and drinks provided by master chef Wolfgang Puck who will bring his uber-popular coffee line to the highly-anticipated Red Carpet Luxury Lounge. Like his food, the 100% arabica coffees are grown naturally, harvested from small estates and handpicked. Upon arrival, the talent and press will indulge in the magical transforming cappuccinos, lattes, mochaccinos and espressos crafted with organic enhancers. The Red Carpet Luxury Lounge is proud to announce its platinum sponsor Wen Hair and Body Care by Chaz Dean. Created in 1993 by renown “hairstylist to the stars”, Chaz Dean completely stopped using lathering products in his hair and went on to create gentle co-cleansing conditioners that were natural, yet effective. Since then Chaz has led the co-washing movement for decades with his line of Cleansing Conditioners and styling products that create natural, healthy, and soft hair. Wen Hair and Body Care by Chaz Dan will be offering exclusive hair services to guests at the event. Other event highlights include a fabulous FashionOmics LIVE Lounge! featuring beauty services from Lashes by Michelle Fong – Dial M Beauty, Massage by Cecilia Alcala; Manicures,Waves, Braids & TopKnots by TONI&GUY; YouTube Make-up Artists Niki Reitano and Aly Ashford; STORM Instant Wrinkle Lift Serum applications by Cosmetic Research Laboratories; botox and gift certificates by Parfaire Medical Aesthetics; and Celebrity Gold Face Mask and decollate, neck and hand treatment by European Skin and Massage Studio. For the first time ever, every guest that attends the Red Carpet Style Lounge will receive an all inclusive 5 night stay at one of Elite Island Resorts fabulous Caribbean properties. Select lucky nominees will also be gifted much coveted ultra exclusive 5-star vacation packages courtesy of Pacific Resort Aitutaki, Cook Islands’ only member of the Small Luxury Hotels of the World collection and The Reef by CuisinArt Anguilla, also a member of Small Luxury Hotels and sister property to the CuisinArt Golf Resort & Spa. Guests will also be introduced to and gifted new and exciting products from Attipas, Auspect Skincare International, Julie's Real Foods LLC, The Gottlieb Native Garden, Allomind, European Skin and Massage Studio, Axia Medical Solutions, Croatian National Tourist Board, SKECH, Keyano Aromatics International, Inc, Bobble Art USA, Keiichiroyuri, Pasta chips, Goodie Girl Cookies, Doery Aromatherapy, Forever In My Heart Jewelry, Vivajennz, Cavalleri, Sally Snacks Venison Jerky Dog Treats, Cosmetic Research Laboratories LLC, Catiques, Dermis RX Advanced Skin Care and Pets People Planet Connection. Upon exiting guests will have also receive a gift bag full of goodies from Dermatologic Cosmetic Laboratories, Silc Skin, ChapStick Total Hydration Moisture + Tint, Emily Cho handbags, Brownie Brittle, Rachel Tribble, Guylian USA Inc, Sasaki Advanced Aesthetic Medical Center, Pretty Woman, NBTY Global Inc, US Organic, Leuchtturm 1917, BLK BLU NYC, Eco Tools, Taymor, Hero Nutritionals, Spoiled Naturally, Yankee Candle, Green Goo by Sierra Sage, Yazzii, Anastasia Beverly Hills, Justins, LL Bean, Eveden, Hey Lady Shoes, Texture The Magazine App, Feel Good Photos By Sasha, Trimfoot, Olde Armoury Leather, New Beauty, artnaturals, Black Stallion Winery and Imedeen Prime Renewal. The Red Carpet Style and Beauty Lounge will benefit Best Friends Animal Society, the only national animal welfare organization focused exclusively on ending the killing of dogs and cats in America's shelters. A leader in the no-kill movement, Best Friends runs the nation's largest no-kill sanctuary for companion animals, as well as lifesaving programs in partnership with more than 1,300 rescue groups and shelters across the country. In Los Angeles, Best Friends leads the No-Kill Los Angeles (NKLA) initiative, which is focused on ending the killing of dogs and cats in city shelters by 2017, and operates two centers, the NKLA Pet Adoption Center in West L.A. and the Best Friends Pet Adoption and Spay/Neuter Center in Mission Hills. Since its founding in 1984, Best Friends has helped reduce the number of animals killed in American shelters from 17 million per year to an estimated 4 million. About Secret Room Events: Secret Room Events is a brand and product marketing firm with niche appeal in the entertainment industry, producing exclusive swag bags, gift lounges and private events for Hollywood's most influential people. FOR MEDIA INTERESTED IN COVERING THE EVENT: Please contact rsvp(at)secretroomevents(dot)com
News Article | February 17, 2017
Global Ophthalmology Devices Market Forecast to 2024 - New report by Data Bridge Market Research Global ophthalmology devices market is expected to reach USD 66.6 billion by 2024 from USD 55.1 billion in 2016, at a CAGR of 2.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Dallas, TX, February 17, 2017 --( The Global Ophthalmology Devices Market is segmented on the basis of product type, application, end-user, distribution channel and geography. Based on product type the global ophthalmology devices market is segmented into diagnostic and monitoring devices, surgical devices and vision care. The diagnostic and monitoring devices market segment is further segmented into optical coherence therapy (OCT) scanners, ophthalmology ultrasound imaging systems, fundus cameras, opthalmoscopes, retinoscopes, wavefront abberrometers, corneal topography, autorefractors, keratometers, specular microscopes, visual field analyzers, tonometers and slit lamps. Based on application type cataract surgery, vision care, ophthalmic woundcare and oculoplastics. On the basis of end users into Hospitals, Academics, Eye Research Institutes, Research laboratories, Diagnosis Clinics, Franchise Optical Stores and, Government agencies. Request for sample pages: https://databridgemarketresearch.com/reports/global-ophthalmology-devices-market-industry-trends-forecast-2024-2/ Basis on geography market is segmented into regions like, North America, Europe, Asia-Pacific, South America and Middle East and Africa. These geographical regions are further segmented into major countries such as US, Canada, Mexico, UK, Germany, France, Spain, Italy, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, and Mexico. Read more: https://databridgemarketresearch.com/global-ophthalmology-devices-market-poised-grow-2-5/ The key players operating in this market are Essilor, Marco, Heidelberg Engineering GmbH, Haag-S Group, Johnson and Johnson Vision Care, Inc. , HOYA GROUP, Abbott Laboratories Inc., CIBA Vision, Nidek Co., Ltd. , Topcon Corporation, Novartis AG, Carl Zeiss AG, Canon Inc., Cooper Vision AG, and Bausch and Lomb Inc, STAAR Surgical Company, Topcon Corporation, Alcon Inc., Bausch & Lomb, Inc. and, Allergan , Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 17, 2017 --( PR.com )-- Global Ophthalmology Devices Market, by Type (Diagnostic & Monitoring Devices (OCT Scanners, Ultrasound, Fundus Cameras, Opthalmoscopes, Retinoscopes, Others), Surgical Devices (Cataract Surgery Devices, Glaucoma Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices) and Vision Care Devices), by Applications (Diagnosis, Surgery, Regular Use), by End-User (Hospitals, Academics, Research Laboratories, Diagnostic Clinics, Franchise Optical Stores, Government Agencies), by Distribution Channel (Retail, Direct Tenders), by Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.The Global Ophthalmology Devices Market is segmented on the basis of product type, application, end-user, distribution channel and geography.Based on product type the global ophthalmology devices market is segmented into diagnostic and monitoring devices, surgical devices and vision care. The diagnostic and monitoring devices market segment is further segmented into optical coherence therapy (OCT) scanners, ophthalmology ultrasound imaging systems, fundus cameras, opthalmoscopes, retinoscopes, wavefront abberrometers, corneal topography, autorefractors, keratometers, specular microscopes, visual field analyzers, tonometers and slit lamps.Based on application type cataract surgery, vision care, ophthalmic woundcare and oculoplastics.On the basis of end users into Hospitals, Academics, Eye Research Institutes, Research laboratories, Diagnosis Clinics, Franchise Optical Stores and, Government agencies.Request for sample pages: https://databridgemarketresearch.com/reports/global-ophthalmology-devices-market-industry-trends-forecast-2024-2/Basis on geography market is segmented into regions like, North America, Europe, Asia-Pacific, South America and Middle East and Africa. These geographical regions are further segmented into major countries such as US, Canada, Mexico, UK, Germany, France, Spain, Italy, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, and Mexico.Read more: https://databridgemarketresearch.com/global-ophthalmology-devices-market-poised-grow-2-5/The key players operating in this market are Essilor, Marco, Heidelberg Engineering GmbH, Haag-S Group, Johnson and Johnson Vision Care, Inc. , HOYA GROUP, Abbott Laboratories Inc., CIBA Vision, Nidek Co., Ltd. , Topcon Corporation, Novartis AG, Carl Zeiss AG, Canon Inc., Cooper Vision AG, and Bausch and Lomb Inc, STAAR Surgical Company, Topcon Corporation, Alcon Inc., Bausch & Lomb, Inc. and, Allergan , Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research
News Article | February 23, 2017
Timmins Gold Corp. (TSX:TMM)(NYSE MKT:TGD) ("Timmins" or the "Company") is pleased to provide an update on its 100% owned Ana Paula project (the "Project") located in the Guerrero Gold Belt, in the State of Guerrero, México. Ana Paula is a high-grade, open pit gold development project that was the subject of a positive Preliminary Economic Assessment ("PEA") in February 2016. In August 2016, the Company initiated a US$9.2 million program of pre-construction activities including feasibility work, infill drilling, metallurgical testing, environmental baseline studies and permitting. The program was designed to allow construction to start on the Project in 2018. Over the past six months significant progress has been made on advancing the Project. Timmins Gold CEO, Greg McCunn, states "After joining the Company earlier this month, I am very encouraged by the progress that has been made at Ana Paula. The results from the infill drilling are validating the previous drilling campaigns and increasing the confidence and robustness of the resource model and our understanding of the lithological domains in the deposit. Metallurgical test work has significantly improved upon the work done in the PEA and validated the suitability of the 6,000 tpd plant that we purchased last year and currently have in storage awaiting the start of construction. It is our intention to provide an interim update on the robust Project economics in the form of a Pre-Feasibility Study (PFS) in Q2 2017, with the full Definitive Feasibility Study (DFS) to be completed by Q1 2018." From October 2016 to the end of January 2017, approximately 7,903 meters of infill drilling in 34 core holes has been completed at the Ana Paula deposit. The objective of the drill program was primarily to carry out infill drilling for supporting an updated Mineral Resource Estimate. Highlights include 48.4 m of 12.16 g/t Au at 136 m downhole in hole AP-16-252, and 151 m of 8.98 g/t Au at 105 m downhole in AP-16-253. The infill drilling is expected to be completed by the end of this month. The Company has retained AGP Mining Consultants (AGP) of Toronto to act as the independent Qualified Persons in updating the Mineral Resource Estimate beginning in March. AGP have also been engaged to carry out mine planning and engineering work for the Project feasibility studies. Geotechnical drilling to support the mine planning work is expected to start in early March which will greatly enhance the confidence in the pit slope design. The complete set of drill results can be accessed on-line at http://www.timminsgold.com/_resources/anapaula/update/feb23.pdf along with a map of the drill hole locations and a selection of sections through the deposit. Metallurgical test work for the Project is being carried out at Blue Coast Research Laboratories in Parksville, British Columbia. Metallurgical samples from drill core were compiled to represent the four types of mineralized lithological domains found at Ana Paula: All comminution, gravity, flotation and leach testing (described below) was carried out on individual domain samples and on life-of-mine composites. The average grade of composite samples for test work was 2.26 g/t gold. Comminution testing including JK Lite simulation (rotary breakage tests) were undertaken on the composite samples and individual domain samples. Simulation and bond work index results have confirmed that the 6,000 tpd Semi-Autogenous Grinding (SAG) and Ball Mill circuit that was purchased by the Company is suitable for treating the Ana Paula material. A Gravity Recoverable Gold testing program (with size-by-size analyses) was carried out. Samples consistently showed very good gravity response with gravity recovery to concentrates of 40-50%. Additionally the gravity concentrates leached very well in a simulated intensive leach reactor, with gold recoveries of 96-98%. A gravity gold recovery circuit including a concentrator and intense cyanide leaching circuit will be added to the process flow sheet. Large (~30 kg) gravity tests were conducted at various grind sizes in order to generate material for downstream process testing (flotation and/or leaching). Flotation test work confirmed that Ana Paula ore consistently displays very good gold recoveries through rougher flotation, with 95% of gold recovered with a 15-20% mass pull. Leaching test work was conducted to evaluate various process alternatives to improve overall gold recovery, which was estimated in the PEA at 75%. The flowsheet selected as the basis for the feasibility studies was rougher flotation after gravity gold recovery to produce a concentrate, followed by cyanide leaching. Leach recovery was significantly improved when a pre-oxidation of the flotation concentrate was carried out ahead of leaching. Overall gold recovery in the preliminary test work showed an improvement over the PEA to 80-85% with the gravity flotation-pre-oxidation-CIL flowsheet. Further test work is underway which will form the basis of the Process Design Criteria for the feasibility studies. The Company has engaged M3 Engineering to provide feasibility study engineering including process design, mechanical, piping, electrical, instrumentation, civil, bulk earthworks, capital and operating cost estimates. It is expected that M3 will produce a PFS by the end of Q2 2017 which will be based on the updated Mineral Resource estimate and mine plan as well as the latest metallurgical testing. The PFS will provide a much higher level of confidence in the robustness of the project economics then the PEA. The PEA economic analysis showed an after tax Net Present Value (5%) of US$248 million and IRR of 43% at US$1,200/oz gold. Knight-Piesold has been engaged to carry out the engineering and design of the waste dumps and Tailings Storage Facility as well as carry out the study for the pit slope design. The environmental base line study was completed in November 2016. In December 2016, the Company submitted an Environmental Impact Assessment (EIA) to SEMARNAT (Mexico's Secretary of Environment and Natural Resources), using the baseline study as its basis. The areas covered in the baseline study are climate, hydrology, hydrogeology, aquifer vulnerability, soil type, earthquake risk, geotechnical, surface water, underground water, and environmental risk. If no further information is required, SEMARNAT guides to a maximum timeline of 120 business days for approval. Up to the current date, Timmins has not received a request from SEMARNAT for further information related to its EIA submission. The next major submission to SEMARNAT would be the Change of Land Use submission, which is expected to occur in Q2 2017. The Company expects to receive construction permits in Q4 2017. As the Company advances its engineering studies, it will also begin to investigate financing alternatives for the Project including project or corporate debt. It is expected that financing will be arranged in conjunction with the completion of the DFS by early 2018. The drilling results contained in this news release have been prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects. Duplicates, standards and blanks were inserted into the sampling stream at intervals of 25 samples. The sampling of, and assay data from, drill core is monitored through the implementation of a quality assurance / quality control (QA-QC) program designed to follow industry best practice. Drill core (HQ size) samples are selected by the Company's geologists and sawn in half with a diamond saw at the project site. Half of the core is retained at the site for reference purposes. Sample intervals vary from 1 to 1.5 m in length. Samples are prepared at the ALS Lab facilities in Guadalajara and analyzed using a standard fire assay with a 50 gram pulp and Atomic Absorption (AA) finish at the ALS lab in Vancouver, Canada. Any samples assaying >10.0g/t Au are automatically re-analyzed using a Gravimetric finish. Check assays were sent to each lab and were cross referenced and results verified. This news release was reviewed and approved by Taj Singh, M.Eng, P.Eng, Vice-President of Engineering and Project Development of the Company, who is recognized as a Qualified Person ("QP") under the guidelines of National Instrument 43-101. Timmins Gold is a Canadian gold mining company engaged in exploration, development and production exclusively in Mexico. Its principal assets include the producing San Francisco mine in Sonora, Mexico and the development stage Ana Paula project in Guerrero, Mexico. The Company also has a portfolio of other exploration properties, all of which are located in Mexico. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) nor the New York Stock Exchange MKT accepts responsibility for the adequacy or accuracy of this news release. Certain statements contained herein may constitute forward-looking statements and are made pursuant to the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Forward-looking statements are statements which relate to future events including: estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, objectives and expectations, including with respect to production, exploration drilling, reserves and resources, exploitation activities and events or future operations. Information inferred from the interpretation of drilling results and information concerning mineral resource estimates may also be deemed to be forward-looking statements, as it constitutes a prediction of what might be found to be present when, and if, a project is actually developed. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans, "anticipates", believes", "estimates", "predicts", "potential", or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggestions herein. Except as required by applicable law, the Company does not intend to update any forward-looking statements to conform these statements to actual results. The Company is subject to the reporting requirements of the applicable Canadian securities laws, and as a result it reports its mineral reserves and resources according to Canadian standards. Canadian reporting requirements for disclosure of mineral properties are governed by NI 43-101. The definitions of NI 43-101 are adopted from those given by the Canadian Institute of Mining, Metallurgy and Petroleum. U.S. reporting requirements are governed by Industry Guide 7 ("Guide 7") of the Securities and Exchange Commission (the "Commission"). These reporting standards have similar goals in terms of conveying an appropriate level of confidence in the disclosures being reported, but embody different approaches and definitions. For example, under Industry Guide 7, mineralization may not be classified as a "reserve" unless the determination has been made that the mineralization could be economically and legally produced or extracted at the time the reserve determination is made. In particular, the Company reports "resources" in accordance with NI 43-101. While the terms "Mineral Resource", "Measured Mineral Resource", "Indicated Mineral Resource" and "Inferred Mineral Resource" are recognized and required by Canadian regulations, they are not defined terms under standards of the Commission and generally, U.S. companies are not permitted to report resources in documents filed with the Commission. As such, certain information contained in this press release concerning descriptions of mineralization and resources under Canadian standards is not comparable to similar information made public by United States companies subject to the reporting and disclosure requirements of the Commission. In addition, an Inferred Mineral Resource has a great amount of uncertainty as to its existence and as to its economic and legal feasibility, and it cannot be assumed that all or any part of an Inferred Mineral Resource will ever be upgraded to a higher category. Under Canadian rules, estimates of Inferred Mineral Resources may not form the basis of any economic studies beyond Preliminary Economic Assessment. It cannot be assumed that all or any part of Measured or Indicated Resources will ever be converted into Mineral Reserves, and it cannot be assumed that all or any part of an Inferred Mineral Resource exists, or is economically or legally mineable. In addition, the definitions of "Proven Mineral Reserves" and "Probable Mineral Reserves" under CIM standards differ in certain respects from the standards of the Commission
News Article | February 27, 2017
Therapeutic Systems Research Laboratories (TSRL), Inc., announced today that the company was awarded a Phase I SBIR grant from the National Institute of Allergy & Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
News Article | February 24, 2017
Research and Markets has announced the addition of the "Global Empty Capsules Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Empty Capsules Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $2.9 billion by 2025. This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. Some of the prominent trends that the market is witnessing include increasing demand for empty capsules in nutraceutical industry, increasing investments in research & development, and recent technological developments of empty capsules. Based on product type the market is categorized into non-gelatin capsules, gelatin capsules. Further, non-gelatin capsules are classified into pullulan and starch material, hydroxy propyl methy cellulose (hpmc). gelatin capsules are divided into bone meal, pig meat gelatin, bovine derived, and other gelatin capsules. On basis of therapeutic application the market is segmented by antianemic preparations (hematenic preparations), cough and cold preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cardiovascular therapy drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, and other therapeutic applications. Depending on the end user the market is segmented by research laboratories, pharmaceutical industry, cosmetics industry, and nutraceutical industry. - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments 3 Market Overview 3.1 Current Trends 3.1.1 Increasing demand for empty capsules in nutraceutical industry 3.1.2 Increasing investments in research & development 3.1.3 Recent technological developments of empty capsules 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 3.4.1 Bargaining power of suppliers 3.4.2 Bargaining power of buyers 3.4.3 Threat of substitutes 3.4.4 Threat of new entrants 3.4.5 Competitive rivalry 4 Empty Capsules Market, By Product 4.1 Non-Gelatin Capsules 4.1.1 Non-Gelatin Capsules Market Forecast to 2025 (US$ MN) 126.96.36.199 Pullulan and Starch Material 188.8.131.52.1 Pullulan and Starch Material Market Forecast to 2025 (US$ MN) 184.108.40.206 Hydroxy Propyl Methy Cellulose (HPMC) 220.127.116.11.1 Hydroxy Propyl Methy Cellulose (HPMC) Market Forecast to 2025 (US$ MN) 4.2 Gelatin Capsules 4.2.1 Gelatin Capsules Market Forecast to 2025 (US$ MN) 18.104.22.168 Bone Meal 22.214.171.124.1 Bone Meal Market Forecast to 2025 (US$ MN) 126.96.36.199 Pig Meat Gelatin 188.8.131.52.1 Pig Meat Gelatin Market Forecast to 2025 (US$ MN) 184.108.40.206 Bovine Derived 220.127.116.11.1 Bovine Derived Market Forecast to 2025 (US$ MN) 18.104.22.168 Other Gelatin Capsules 22.214.171.124.1 Other Gelatin Capsules Market Forecast to 2025 (US$ MN) 5 Empty Capsules Market, By Therapeutic Application 5.1 Antianemic Preparations (Hematenic Preparations) 5.1.1 Antianemic Preparations (Hematenic Preparations) Market Forecast to 2025 (US$ MN) 5.2 Cough and Cold Preparations 5.2.1 Cough and Cold Preparations Market Forecast to 2025 (US$ MN) 5.3 Anti-Inflammatory Drugs 5.3.1 Anti-Inflammatory Drugs Market Forecast to 2025 (US$ MN) 5.4 Antibiotic and Antibacterial Drugs 5.4.1 Antibiotic and Antibacterial Drugs Market Forecast to 2025 (US$ MN) 5.5 Cardiovascular Therapy Drugs 5.5.1 Cardiovascular Therapy Drugs Market Forecast to 2025 (US$ MN) 5.6 Vitamins and Dietary Supplements 5.6.1 Vitamins and Dietary Supplements Market Forecast to 2025 (US$ MN) 5.7 Antacid and Antiflatulent Preparations 5.7.1 Antacid and Antiflatulent Preparations Market Forecast to 2025 (US$ MN) 5.8 Other Therapeutic Applications 5.8.1 Other Therapeutic Applications Market Forecast to 2025 (US$ MN) 6 Empty Capsules Market, By End User 6.1 Research Laboratories 6.1.1 Research Laboratories Market Forecast to 2025 (US$ MN) 6.2 Pharmaceutical Industry 6.2.1 Pharmaceutical Industry Market Forecast to 2025 (US$ MN) 6.3 Cosmetics Industry 6.3.1 Cosmetics Industry Market Forecast to 2025 (US$ MN) 6.4 Nutraceutical Industry 6.4.1 Nutraceutical Industry Market Forecast to 2025 (US$ MN) - Acg Worldwide - Roxlor, LLC - JC biological technologies. - Suheung Co Ltd. - Qualicaps - Nectar Lifesciences Ltd - Capscanada Corporation - Sunil Healthcare Limited - Capsugel - Medi-Caps Ltd. - Patheon Ltd - Snail Pharma Industry Co., Ltd. - Bright Pharmacaps Inc. For more information about this report visit http://www.researchandmarkets.com/research/8thdmr/global_empty
News Article | November 24, 2016
The global ultra-low temperature freezers market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. The rising R&D expenditure in biomedical industry and better option from conventional cascade is boosting the revenues per year. The global market for Ultra-Low Temperature Freezer is expected to reach USD 701.4 million by the end of the forecasted period and is expected to grow at a CAGR of 2.7%. Increasing need for high power efficiency products is one of the major factors driving the growth of the global Ultra-Low Temperature Freezers Market by 2022 Ultra-low temperature freezers are used for the storage of the samples, vaccines, medicine among others. They have the range of temperature between - 46C to - 86C. The market for ULT Freezer Market is growing with increasing need of development in biomedical industry. Among the type; upright ULT freezers and chest ULT freezers are compositing the growth of the market. It is projected to grow rapidly from the period of 2013 to 2022. Test the market data and market information presented through more than 45 market data tables spread over 86 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on the “Global Ultra-Low Temperature Freezers Market Research Report - Forecast to 2022” The key players in this market are keen in developing the existing ULT freezers. The companies like Thermo Fishers and Panasonic Healthcare have developed more energy efficient ultra-low temperature freezers that could save more than 20% of the energy consumed by the ULT freezers. With these developments the market for ULT freezers is expected grow increase exponentially. Table 5 Global Ultra-Low Temperature Freezer Market, For Bio-Banks, By Region, 2013 To 2022 (USD Million) Table 6 Global Ultra-Low Temperature Freezer Market, For Hospitals & Clinics, By Region, 2013 To 2022 (USD Million) Table 7 Global Ultra-Low Temperature Freezer Market, For Academic & Research Laboratories, By Region, 2013 To 2022 (USD Million) In recent years the investment for biomedical R&D by Asian countries like China, South Korea, India, Japan and others subsequently increased when compared to North America and Europe. Vigorous efforts taken by the manufacturers to improve the power-efficiency and other technological advancement has boosted the growth of the market. In the coming years, it is expected that the global ultra-low temperature freezers market will advance with higher growth rate as compared to previous years. Global Astigmatism Market Information, by type (Myopic Astigmatism, Hyperopic Astigmatism and others), by treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries and others), by end user (Hospital, Clinics and others) - Forecast to 2022 https://www.marketresearchfuture.com/reports/astigmatism-market-research-report-global-forecast-to-2022